首页 › 基金 › Ikarian Capital, LLC › MRNA
Ikarian Capital, LLC 对 MRNA 的持仓历史
MODERNA INC · 医疗保健
Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 MRNA(MODERNA INC)400,000 股,市值约 US$77.0M,约占其申报组合的 11.31%,在其申报持仓中市值排名第 1 位。 Ikarian Capital, LLC 最近 13 个申报季度中有 5 个季度披露了 MRNA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Ikarian Capital, LLC 对 MRNA 的持仓演变
Ikarian Capital, LLC 于 Q3 2023 首次披露 MRNA 持仓:2,443 股(约 US$25.2M)。 该持仓在 Q3 2026 达到峰值 400,000 股,市值约 US$77.0M。 在 5 次申报中,Ikarian Capital, LLC 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 400,000 股、市值约 US$77.0M。 持仓曾出现大幅变动:Q4 2023 增持约 905% (随后一个季度股价上涨 7%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.44K | $25.23M | 新进 |
| Q4 2023 | 24.55K | $2.44M | 增持 |
| Q4 2024 | 100.00K | $4.16M | 新进 |
| Q2 2026 | 400.00K | $28.01M | 新进 |
| Q3 2026 | 400.00K | $77.03M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MRNA 与 13F 数据
MRNA(MODERNA INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 MRNA,申报仓位最大的包括:富达投资(FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford (US$2.20B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MRNA 的基金
- 富达投资(FMR) 58.96M 股 · $11.35B · Q3 2026
- Capital World Investors 22.64M 股 · $4.36B · Q3 2026
- Baillie Gifford 11.44M 股 · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M 股 · $1.28B · Q3 2026
- Flagship Pioneering, LLC 4.63M 股 · $892.01M · Q3 2026
- IMC-Chicago, LLC 3.07M 股 · $590.92M · Q3 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.42M 股 · $466.58M · Q3 2026
- Merck & Co., Inc. 2.31M 股 · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M 股 · $414.27M · Q3 2026
- a16z Perennial Management, L.P. 1.52M 股 · $292.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.40M 股 · $269.60M · Q3 2026
- BAMCO INC /NY/ 1.39M 股 · $267.88M · Q3 2026
更多关于 Ikarian Capital, LLC
常见问题
How long has Ikarian Capital, LLC held MRNA?
Ikarian Capital, LLC has disclosed MRNA holdings in 5 of the last 13 reported quarters, going back to Q3 2023.
What is Ikarian Capital, LLC's current position in MRNA?
As of Q3 2026, Ikarian Capital, LLC holds 400.00K shares of MRNA (MODERNA INC), valued at $77.03M, representing 11.31% of its reported portfolio and ranking #1.
Has Ikarian Capital, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC held unchanged its position in MRNA. The position peaked in Q3 2026 at 400.00K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include 富达投资(FMR), Capital World Investors, Baillie Gifford, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.